Ultragenyx Pharmaceutical Inc. buy The Goldman Sachs Group, Inc.
Start price
02.08.24
/
50%
€46.20
Target price
02.08.25
€69.62
Performance (%)
0.00%
Price
01.08.24
€41.20
Summary
This prediction is currently active. The_Goldman_Sachs_Gr's BUY prediction for Ultragenyx Pharmaceutical Inc. is currently unchanged. This prediction currently runs until 02.08.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Ultragenyx Pharmaceutical Inc. | 0.00% |
iShares Core DAX® | -3.935% |
iShares Nasdaq 100 | -3.608% |
iShares Nikkei 225® | -4.513% |
iShares S&P 500 | -2.607% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $67.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.80
06.06.24
06.06.24
€61.55
06.06.25
06.06.25
13.24%
01.08.24
01.08.24